Buyout Private Equity Fund
The "Turing M&A Fund" has successfully raised its first round of funding, totaling NT$300 million, with an investment from Shih-Kai Precision (Stock Code: 2063).
The total expected fundraising target is approximately NT$500 million to NT$1 billion.
日 期：2024年10月24日
公司名稱：世鎧 (2063)
主 旨：世鎧投資圖靈一號併購投資有限合夥成立之私募股權基金
發言人：鄭守傑
1
Fund Overview
Fund Name: Turing No.1 M&A Investment Limited Partnership
Fund Type: Private Equity Buyout Fund
Investment Target: Publicly listed companies in Taiwan
Fund Duration: 2023 – 2031
Management Company: Turing M&A Investment Co., Ltd.
Financial Statement Auditor: Deloitte Taiwan CPA Shulin Liu
Investment Committee: Arthur Chang, Lai-Shou Su, Stanley Tan
Regulatory Approval: Ministry of Economic Affairs
Approval Document No.: 11234700570
Minimum Investment: NTD 10 million
Fund Features
High Liquidity
Redemptions available quarterly after one year.
Leverage & Amplified Returns
Utilize strategic investments to maximize profits.
First-Mover Advantage
Taiwan’s first M&A investment + shareholder activism fund.
Learning Curve
Gain expertise in Taiwan’s M&A investments and shareholder activism strategies.
Tailor-Made Structure
Flexible and customizable partnership and management agreements.
2
Fund Timeline
2023 Q1
Initial fund planning
2023 Q2
Official fund establishment
2024 Q3 onward
Fundraising begins
2025–2026
Finalize target selection, complete public acquisition, and secure company control
2026–2029
Conduct follow-up acquisitions and obtain board seats
2030–2031
Execute exit strategy
3
Fund Advantages
Regulatory Initiatives
In March 2023, Taiwan’s Financial Supervisory Commission (FSC) announced an eight-year "Sustainable Development Action Plan" for listed companies, introducing the "Collective Negotiation Platform" and establishing proxy advisory firms.
Legal & Policy Support
In July 2018, Taiwan’s Legislative Yuan passed amendments to the Company Act, enhancing shareholder rights and corporate governance.
Undervalued High-Quality Companies
Around 100 listed and 80 over-the-counter (OTC) companies meet 10 key financial indicators, presenting attractive investment opportunities.
Abundant & Low-Cost Capital
Taiwan’s bank lending rates are among the lowest in the world, making it an ideal environment for leveraged buyouts (LBOs).
Succession Issues in Family Businesses
Many Taiwanese listed and OTC companies have highly dispersed ownership and face challenges with second-generation successors unwilling to take over, creating strategic acquisition opportunities.